Sean Dunleavy
Foot & Ankle Surgery · Anchorage, AKNPI 1285021725
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (60.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 62.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $2,460 and has fallen 98.2% since, to $44 in 2025.
Across 37 payments — averaging $113.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Organogenesis Inc.$472
- Stryker$302
- DJO, LLC$206
- Orthofix Medical, Inc.$135
- Amgen$120
- plus $364 from 10 others
What the payments were for
- Speaking & faculty fees$1253%
- Food & beverage$1,55837%
- Education$2,52360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 10 | $2,606 |
| Organogenesis Inc. | 8 | $472 |
| Stryker | 3 | $302 |
| DJO, LLC | 3 | $206 |
| Orthofix Medical, Inc. | 1 | $135 |
| Amgen | 2 | $120 |
| Crossroads Extremity Systems, LLC | 1 | $120 |
| Cardiovascular Systems Inc. | 1 | $77 |
| Smith+Nephew | 1 | $29 |
| Bioventus LLC | 1 | $27 |
| Boston Scientific | 1 | $24 |
| Medtronic | 1 | $22 |
| AbbVie | 1 | $19 |
| Alaska Medical Technologies, LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| ERMI LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CMF OL1000$148
- T2$148
- Physio-Stim Osteogenesis Stimulator$135
- ANCHORAGE$134
- PuraPly$125
- Apligraf$125
- Dermagraft$125
- Puraply/Affinity/NuTech$125
- Puraply Antimicrobial$125
- KRYSTEXXA$101
How this compares
$4,206 in reported general payments places this provider in the 70th percentile of 21 foot & ankle surgery providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 38 | $817 |
| Ciclopirox | 12 | $286 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Anchorage
- Regina FiaccoAnchorage$18K
- Sheryse MobleyAnchorage$15K
- Rabun FoxAnchorage$8K
- Eugene ChangAnchorage$7K
- Chloe MulliganAnchorage$4K
- Jennifer JansmaAnchorage$2K
- Jared KernAnchorage$2K
- Namory BagayokoAnchorage$1K
- Caitlin KoellingAnchorage$913
- Matt HeilalaAnchorage$679
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.